1) Hormone-producing pituitary adenomas
分泌型垂体瘤
2) pituitary GH-secreting adenoma
垂体GH分泌瘤
3) human prolactin pituitory adenoma
人泌乳素型垂体瘤
4) Macroprolactinomas
泌乳素型垂体腺瘤
1.
Causes for Bad Compliance on Taking Bromocriptine in Patients with Macroprolactinomas and the Counterplans
影响泌乳素型垂体腺瘤患者服药依从性的原因及对策
5) Ki-67 HUMARA
多激素分泌性垂体腺瘤
6) Prolactinoma
垂体泌乳素腺瘤
1.
Relationship between NGFR Expression and Biological Characters in Pituitary Prolactinomas;
神经生长因子受体在垂体泌乳素腺瘤中的表达及其与肿瘤生物学特点的相关性研究
2.
Part I Study of correlativity between the NGFR expression and thebiological characters in prolactin-secreting pituitary adenomaObjective To explore the relationship between the expression of two receptors of nerve growth factor(NGF) , proliferation nuclear antigen (PCNA) and the biological characters of Prolactinomas.
第一部分 神经生长因子受体(NGFR)在垂体泌乳素腺瘤中的 表达及与肿瘤生物学特点的相关性研究目的探讨垂体泌乳素腺瘤中神经生长因子受体及增殖细胞核抗原(PCNA)表达与PRL腺瘤生物学特性之间的相关性。
3.
Clinical characteristic and cost—effectiveness analysis of two therapeutic methods of prolactinoma BACKGROUND Prolactin-secreting tumors are the most common and account for about 40 to 60 percent of all the hormonr-secreting pituirary tumors.
垂体泌乳素腺瘤的临床特点及应用手术和药物两种治疗方案的成本效果分析 研究背景 垂体泌乳素腺瘤是最常见的垂体肿瘤，约占垂体肿瘤的40％～60％。
补充资料：多发性内分泌腺瘤I型
多发性内分泌腺瘤I型
参见"多发性内分泌腺病"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条